Trevi Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Trevi Therapeutics Inc
CIK #0001563880
EDGAR Form CIK 2011 - 2026
10-K [0001563880]
10-Q [0001563880]
3 [0001563880]
4 [0001563880]
5 [0001563880]
8-K [0001563880]
D [0001563880]
SC 13D [0001563880]
SC 13G [0001563880]
Form 13D/13G Filer Form 13D/13G Subject Filed
FMR LLC Trevi Therapeutics Inc [2026-02-05]
Vanguard Group Inc Trevi Therapeutics Inc [2026-01-30]
BlackRock Inc Trevi Therapeutics Inc [2025-10-17]
Rubric Capital Management LP Trevi Therapeutics Inc [2025-07-09]
Rosalind Advisors Inc Trevi Therapeutics Inc [2023-02-15]
Rubric Capital Management LP Trevi Therapeutics Inc [2023-02-10]
Viking Global Investors LP Trevi Therapeutics Inc [2022-10-07]
Venrock Healthcare Capital Partners II LP Trevi Therapeutics Inc [2022-04-21]
Fairmount Funds Management LLC Trevi Therapeutics Inc [2022-04-21]
Frazier Life Sciences Public Fund LP Trevi Therapeutics Inc [2022-04-18]
View All
Form 3/4/5 Subject 2011 - 2026
Mathers Edward T
Trevi Therapeutics Inc
Heffernan Michael Thomas
Colangelo Dominick
Vanlent Anne
Meeker David P
Simon Farrell
Good Jennifer L
Sciascia Thomas
Galletta Christopher
Cassella James V
Behbahani Ali
Sandell Scott D
Chang Carmen
Makhzoumi Mohamad
Baskett Forest
Florence Anthony A Jr
NEA Partners 16 LP
New Enterprise Associates 16 LP
NEA 16 GP LLC
Walker Paul Edward
Hastings David C
Delfini Lisa
Clark David J
TPG GP A LLC
Coulter James G
Bonderman David
Winkelried Jon
Forbes William P
Sonsini Peter W
Muscolo Frank P
Seiter Christopher
Makower Joshua
TPG Group Holdings SBS Advisors Inc
Brett-Smith Helena
Mazabraud Yann
Barris Peter J
Mott David M
Lundbeckfond Invest A/S
Richard King Mellon Foundation
Agger Mette Kirstine
Aperture Venture Partners IV LP
Aperture Ventures IV Management LLC
Oshea William J
MFIC V LLC
Mellon Family Investment Co V
Omega Fund V LP
Omega Fund V GP Manager Ltd
Mitsak Anna Guyer
Omega Fund V GP LP
Drake Peter F
Drake Debra A
Nadav Eran
O'shea William J
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Trevi Therapeutics Inc TRVI
Stock Option (right to buy) · derivative
2026-02-19 Grant 675,000 $0.00
Trevi Therapeutics Inc TRVI
Stock Option (right to buy) · derivative
2026-02-19 Grant 35,000 $0.00
Trevi Therapeutics Inc TRVI
Stock Option (right to buy) · derivative
2026-02-19 Grant 215,000 $0.00
Trevi Therapeutics Inc TRVI
Stock Option (right to buy) · derivative
2026-02-19 Grant 160,000 $0.00
Trevi Therapeutics Inc TRVI
Stock Option (right to buy) · derivative
2026-02-19 Grant 85,000 $0.00
Trevi Therapeutics Inc TRVI
Stock Option (right to buy) · derivative
2026-01-08 Grant 375,000 $0.00
Trevi Therapeutics Inc TRVI
Common Stock
2025-12-02 Option exercise 4,225 $0.51 2,155
Trevi Therapeutics Inc TRVI
Stock Option (right to buy) · derivative
2025-12-02 Option exercise 4,225 $0.00
Trevi Therapeutics Inc TRVI
Nonstatutory Stock Option (right to buy) · derivative
2025-06-11 Grant 45,000 $0.00
Trevi Therapeutics Inc TRVI
Nonstatutory Stock Option (right to buy) · derivative
2025-06-11 Grant 45,000 $0.00
Trevi Therapeutics Inc TRVI
Nonstatutory Stock Option (right to buy) · derivative
2025-06-11 Grant 45,000 $0.00
Trevi Therapeutics Inc TRVI
Nonstatutory Stock Option (right to buy) · derivative
2025-06-11 Grant 45,000 $0.00
Trevi Therapeutics Inc TRVI
Nonstatutory Stock Option (right to buy) · derivative
2025-06-11 Grant 45,000 $0.00
Trevi Therapeutics Inc TRVI
Performance Stock Option (right to buy) · derivative
2025-05-31 Grant 60,000 $0.00
Trevi Therapeutics Inc TRVI
Performance Stock Option (right to buy) · derivative
2025-05-31 Grant 72,000 $0.00
Trevi Therapeutics Inc TRVI
Performance Stock Option (right to buy) · derivative
2025-05-31 Grant 102,000 $0.00
Trevi Therapeutics Inc TRVI
Performance Stock Option (right to buy) · derivative
2025-05-31 Grant 8,550 $0.00
Trevi Therapeutics Inc TRVI
Performance Stock Option (right to buy) · derivative
2025-05-31 Grant 72,000 $0.00
Trevi Therapeutics Inc TRVI
Common Stock
2025-04-17 Option exercise 1,851,852 $1.37 2,537,037
Trevi Therapeutics Inc TRVI
3.5-Year Common Stock Warrant · derivative
2025-04-17 Option exercise 1,851,852 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com